Covance has invested in mass spectrometer technology that it hopes
will give it the edge over other contract research organisations
(CROs) in the safety testing of new drug candidates.
US-based drug maker Merck, has agreed to outsource some of its
preclinical trial work to an Indian-based company, marking the
first time the pharma giant has used an Indian company to conduct
drug research.
Animal welfare group, PETA has reportedly targeted Pfizer, accusing
them of also trying to avoid US animal welfare laws by exporting
its animal testing to countries with no or poor animal welfare
standards.
Merck and Chi-Med have announced the start of their collaboration,
which aims to discover novel small molecule anti-cancer drugs
derived from natural products that modulate oncological pathways.
Pharmaceutical company Eli Lilly, has been asked to justify its
decision to outsource its animal testing to countries with no or
poor animal welfare standards, which go against Lilly's commitment
to reducing, refining, and replacing...
The US government to pass new measures that make prosecuting
animal-rights activists who target enterprises much easier. The
move has lead critics to warn that peaceful demonstrators would be
labelled as terrorists.
Accelrys are to expand its Discovery Studio software environment
with new and enhanced life science modelling and simulation
functionality, which is set to deliver a broader range of tools for
drug discovery in one environment.
Asterand is to make available novel research materials to be used
in the investigation of rheumatoid arthritis, osteoarthritis,
cancer and other diseases making available a range of cell material
that is currently difficult to obtain.
Ground Zero Pharmaceuticals (GZP) has announced an expansion to the
services it offers enabling the expansion into more of its clients'
late-stage development programs, with the potential for creating
submissions that lead to...
Curalogic, a Danish biotechnology company, has appointed SAFC's
Pharma business segment to provide protein isolation, extraction
and purification services as part of its product development to
treat Allergic Rhinitis.
Charles River Laboratories has been awarded a $111.6m (€89m),
10-year contract from the National Cancer Institute (NCI), doubling
the size of the company's current contract with NCI.
For pharma companies that are hesitant about outsourcing during the
drug discovery stage, a world of opportunity awaits.
OutsourcingPharma.com gives a brief run down of what kinds of
services are on offer, as well as a few potential...
Covance has announced it has licensed the use of a technique that
is the only known in-vitro method to predict
in-vivo liver disposition allowing users to identify and
select better drug candidates.
Millipore has now made available its GPCRProfiler screening service
that allows more accurate characterisation of lead compounds
enabling pharmaceutical and biotechnology companies to accelerate
their lead optimisation efforts.
Clinical research organisations (CROs) should be enlisted to run
Phase I oncology drug trials in order to improve efficiencies,
delegates heard at Pabord 2006 in London.
Targeting the market for drug metabolite identification and
biomarker discovery, Tandem Labs has acquired PharmaKD, a
Massachussets-based division of Linden Technologies.
According to the CEO and Chairman of pharmaceutical giant Eli
Lilly, the biomedical breakthroughs that are occurring within the
industry are transforming medicine and promise to ease the
challenges facing an aging population.
GlaxoSmithKline (GSK) has formed a partnership with ChemoCentryx
worth $1.5bn (€1.2bn) which will provide the company with access to
selected targets from one of the broadest pipelines of
chemokine-based therapeutics in the biotech...
Evotec and CHDI have formed a strategic partnership, which aims to
research and develop treatments for Huntington Disease (HD), a
genetic disorder that causes programmed degeneration of brain cells
and loss of intellectual faculties.
Charles River Laboratories becomes the ninth contract research
organisation (CRO) to open up a new pathology facility within the
Chicago Technology Park (CTP), reinforcing the emerging outsourcing
trend in pharmaceutical discovery...
Global drug development spending will top $105bn (€81.5bn) by 2010
and 40 per cent of this business is expected to be dished out in
outsourcing contracts - with contract research organisations (CROs)
emerging triumphant.
Covance, the world's largest provider of drug-development services,
is bracing itself for the onslaught of protests by animal rights
activists who are demonstrating against the building of a $100m
(€78.6) laboratory in the US.
A new service introduced on the back of customer demand has been
launched by Aviva Systems Biology which make available a method for
genome-wide detection of promoters and enhancers that interact with
proteins or carry modifications.
GlaxoSmithKline (GSK) has decided to outsource its research in
genotyping by awarding a contract to Expression Analysis who will
provide the pharma giants with microarray-based genotyping
services.
Aldevron has announced the expansion of its Genetic Immunisation
and Antibody (GIA) facility to meet the increased demand of vaccine
screening contracts.
Despite looming threats from cheap Asian competitors, European
contract research organisations (CROs) still have a fighting chance
in the global R&D outsourcing market, according to a report by
research analysts Frost & Sullivan.
Wyeth has announced that it has selected NovaScreen to conduct a
high-throughput screening (HTS) campaign, which makes use of
Caliper's microfluidic screening platform, which utilises
reproducible electrophoretic separation of...
As clinical trial activity in the Asia Pacific region continues to
boom, Novotech, the largest Australian owned contract research
organisation (CRO) has presented a checklist to help pharma firms
minimise risk when choosing a partner.
As financial pressures continue to plague the pharma industry,
firms should consider taking more advantage of sourcing staff in
cheap labour markets in order to save a buck.
China could be the first country to conduct human stem cell trials
and presents a significant opportunity for Western companies who
are brave enough to use this risky destination as a place to pursue
this potentially lucrative sector...
Covance has stepped up its laboratory testing capabilities in the
Asia Pacific region to satisfy the growing number of sponsors
conducting clinical studies in this budding location.
China-based Natural Pharmatech has formed its first research
contract with a Japanese company, Kobayashi Pharmaceutical -
another step forward in Natural Pharmatech's plans to bring its
botanical R&D services to the global...
Discovery Partners International is offloading its unprofitable
contract drug discovery operations and merging with Infinity
Pharmaceuticals to create a new public company focused on cancer
drug discovery and development.
As China improves its resources and regulatory processes it will
soon become a hotbed of clinical drug research activity, and
position itself as one of the world's most important countries in
this field, according to a new report...
As contract research organisations (CROs) continue to search for
cost-effective countries in which to operate, the clinical trials
market is increasingly expanding into emerging economies. Central
and Eastern Europe are continuing...
Drug companies are leaning more heavily on contract research
organisations (CROs) to save costs in getting new drugs to market.
And it is paying off, with added benefits. Companies who rely on
CROs are also completing clinical trials...
UK's Pharmagene has joined forces with US company Asterand to form
a human tissue supply and research services company that will
dominate the pharma industry. The merger, which was finalised last
week, will also solidify Pharmagene's...
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...
Global regulatory standards govern bioanalytical method development, validation and the subsequent assays. When those standards are updated, industry stakeholders...
Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...